Diferencia entre revisiones de «Sexually transmitted diseases»

Línea 14: Línea 14:
==Management <ref> https://www.cdc.gov/std/treatment-guidelines/STI-Guidelines-2021.pdf </ref>==
==Management <ref> https://www.cdc.gov/std/treatment-guidelines/STI-Guidelines-2021.pdf </ref>==
*Consider empiric treatment for [[Gonorrhea]] and [[Chlamydia]]:
*Consider empiric treatment for [[Gonorrhea]] and [[Chlamydia]]:
**Ceftriaxone 500 mg IM x1 (1g IM for pts > 150 kg) '''AND'''
**[[Ceftriaxone]] 500 mg IM x1 (1g IM for pts > 150 kg) '''AND'''
**Doxycycline 100mg PO BID x 7 days (preferred) '''OR'''
**[[Doxycycline]] 100mg PO BID x 7 days (preferred) '''OR'''
**Azithromycin 1g PO x 1 '''OR'''
**[[Azithromycin]] 1g PO x 1 '''OR'''
**Azithromycin 500 mg PO x 1 and 250mg PO daily x 4 days
**[[Azithromycin]] 500 mg PO x 1 and 250mg PO daily x 4 days


*It is important to treat sexual partners for all STDs
*It is important to treat sexual partners for all STDs

Revisión del 08:29 14 may 2022

Background

Clinical Features

STD Visual Diagnosis (Male)

STD Visual Diagnosis (Female)

Differential Diagnosis

Sexually transmitted diseases

Evaluation

Management [2]

Disposition

See Also

External Links

References